FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Prof. Dr. Falk Nimmerjahn
List of publications:
BibTeX-Download
Lehrstuhl für Genetik
Project Leads
(13)
Project Memberships
(1)
Publications
(192)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
No need for constant help: human IgG2 antibodies have an autonomous agonistic activity for immunotherapy of cancer. (2015)
Lux A, Nimmerjahn F
Journal article
Three blocks are not enough-Blocking of the murine IgG receptor FcγRIV is crucial for proper characterization of cells by FACS analysis (2015)
Biburger M, Trenkwald I, Nimmerjahn F
Journal article, Note
bIgG time for large eaters: Monocytes and macrophages as effector and target cells of antibody-mediated immune activation and repression (2015)
Gordan S, Biburger M, Nimmerjahn F
Journal article, Review article
Sweet and sour: the role of glycosylation for the anti-inflammatory activity of immunoglobulin G. (2014)
Kao D, Böhm S, Nimmerjahn F
Journal article, Review article
Role of sialylation in the anti-inflammatory activity of intravenous immunoglobulin - F(ab')₂ versus Fc sialylation. (2014)
Schwab I, Nimmerjahn F
Journal article, Review article
Fcγ receptors III and IV mediate tissue destruction in a novel adult mouse model of bullous pemphigoid. (2014)
Schulze FS, Beckmann T, Nimmerjahn F, Ishiko A, Collin M, Koehl J, Goletz S, et al.
Journal article
Targeting B cells and autoantibodies in the therapy of autoimmune diseases. (2014)
Kao D, Lux A, Schwab I, Nimmerjahn F
Journal article, Review article
Reply to - IVIG pluripotency and the concept of Fc-sialylation: challenges to the scientist. (2014)
Schwab I, Lux A, Nimmerjahn F
Journal article, other
Broad requirement for terminal sialic acid residues and FcγRIIB for the preventive and therapeutic activity of intravenous immunoglobulins in vivo. (2014)
Schwab I, Mihai S, Seeling M, Kasperkiewicz M, Ludwig RJ, Nimmerjahn F
Journal article
LILR-B1 blocks activating FcγR signaling to allow antibody dependent enhancement of dengue virus infection. (2014)
Nimmerjahn F, Lux A
Journal article, Note
‹
1
...
13
14
15
16
17
...
20
›